Hims & Hers Health (HIMS) Gross Margin (2020 - 2026)
Hims & Hers Health (HIMS) posted Gross Margin of 65.25% for Q1 2026, down 9.29% sequentially from 71.94% in Q4 2025, and down 825.0% YoY from 9.0% in Q1 2025.
Hims & Hers Health (HIMS) Gross Margin (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Gross Margin for 7 years, with the latest figure at 65.25% in Q1 2026.
- Quarterly Gross Margin fell 825.0% year-over-year to 65.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 71.72% (down 533.0% YoY) and the FY2025 annual result came in at 73.84%, down 562.0% from the prior year.
- Gross Margin retreated to 65.25% in Q1 2026 per HIMS's latest filing, from 71.94% in the prior quarter.
- Over five years, Gross Margin peaked at 82.74% in Q4 2023 and troughed at 65.25% in Q1 2026.
- A 5-year average of 77.46% and a median of 79.02% in 2022 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2023 and 2025: Gross Margin soared 664 bps in 2023, then sank 886 bps in 2025.
- Over 5 years, Gross Margin stood at 79.15% in 2022, then rose by 5 bps to 82.74% in 2023, then declined by 7 bps to 76.81% in 2024, then fell by 6 bps to 71.94% in 2025, then dropped by 9 bps to 65.25% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 65.25%, 71.94%, and 73.8% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn | 63.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.83% |
| Mar 31, 2026 | 65.25% |
| Dec 31, 2025 | 71.94% |
| Sep 30, 2025 | 73.80% |
| Jun 30, 2025 | 76.39% |
| Mar 31, 2025 | 73.50% |
| Dec 31, 2024 | 76.81% |
| Sep 30, 2024 | 79.16% |
| Jun 30, 2024 | 81.30% |
| Mar 31, 2024 | 82.36% |
| Dec 31, 2023 | 82.74% |
| Sep 30, 2023 | 82.62% |
| Jun 30, 2023 | 81.84% |
| Mar 31, 2023 | 80.42% |
| Dec 31, 2022 | 79.15% |
| Sep 30, 2022 | 79.02% |
| Jun 30, 2022 | 76.76% |
| Mar 31, 2022 | 73.79% |
| Dec 31, 2021 | 73.32% |
| Sep 30, 2021 | 73.98% |